| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 11.320 | 48.439 | 54.217 | 37.480 | 61.161 | 60.330 | 60.188 | 60.034 | 60.026 | 51.532 |
| Total Income - EUR | 11.365 | 48.439 | 54.339 | 37.495 | 61.161 | 60.347 | 60.337 | 60.038 | 60.041 | 51.532 |
| Total Expenses - EUR | 9.581 | 41.904 | 51.528 | 38.748 | 55.827 | 56.189 | 57.864 | 58.097 | 61.190 | 56.265 |
| Gross Profit/Loss - EUR | 1.784 | 6.535 | 2.811 | -1.253 | 5.334 | 4.158 | 2.473 | 1.941 | -1.149 | -4.733 |
| Net Profit/Loss - EUR | 1.444 | 5.738 | 2.275 | -1.625 | 4.707 | 3.551 | 2.141 | 1.341 | -1.745 | -4.833 |
| Employees | 0 | 1 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Tasprim Com Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | 10.092 | 18.635 | 18.224 | 18.113 | 21.367 | 26.117 | 28.212 | 23.801 | 22.815 | 17.871 |
| Inventories | 5.736 | 15.417 | 10.836 | 12.110 | 14.541 | 16.754 | 19.179 | 17.694 | 15.628 | 10.298 |
| Receivables | 0 | 0 | 0 | 1.612 | 0 | 0 | 0 | 1 | 796 | 918 |
| Cash | 4.356 | 3.218 | 7.388 | 4.391 | 6.826 | 9.362 | 9.032 | 6.106 | 6.392 | 6.655 |
| Shareholders Funds | 9.996 | 15.632 | 17.642 | 15.694 | 20.097 | 23.267 | 24.892 | 20.226 | 18.419 | 13.483 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 96 | 3.003 | 582 | 2.419 | 1.270 | 2.850 | 3.320 | 3.575 | 4.396 | 4.388 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4763 - 4763" | |||||||||
| CAEN Financial Year |
4711
|
|||||||||
Comments - Tasprim Com Srl